On Friday, Chimera Investment Corporation (NYSE:CIM)’s shares inclined 2.35% to $14.81.
Chimera Investment Corporation (CIM) declared that the Board of Directors has declared the second quarter 2015 common stock dividend and set the quarterly dividend for 2015.
2015 Dividends
The Board of Directors of Chimera recently declared the declaration of its second quarter 2015 cash dividend of $0.48 per common share. This dividend is payable July 30, 2015, to common stockholders of record on June 30, 2015. The ex-dividend date is June 26, 2015.
Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes. Its targeted asset classes comprise non-agency RMBS, such as investment-grade and non-investment grade classes; agency RMBS; interest-only RMBS; and first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, and industrial properties.
KKR & Co. L.P. (NYSE:KKR)’s shares gained 0.44% to $23.00.
Bayer AG has reached a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd., a company which is backed by funds sponsored by leading global investment firm KKR and the Panasonic Corporation. The total consideration for the transaction is EUR 1,022 million. The sale will comprise the leading Contour™ portfolio of blood glucose monitoring meters and strips, in addition to other products such as Breeze™2, Elite™ and Microlet™ lancing devices. Closing of the transaction is subject to customary conditions, counting relevant antitrust clearance, and is predictable to occur in the first quarter of 2016.
Johannes Huth , Member and Head of KKR Europe, Africa and Middle East , and Hiro Hirano , Member and CEO of KKR Japan, said, “We are happy that Bayer Diabetes Care chose Panasonic Healthcare and KKR as the trusted partners for bringing the business to its next stage of development. This is another milestone in KKR’s track record of partnering with leading German and Japanese corporates and in growing top health care companies. Together, we will leverage our experience and network to create a global diabetes care solutions powerhouse in an effort to make this a transformational transaction for the diabetes care industry.”
Bayer’s Diabetes Care business is a technological leader in blood glucose monitoring systems, lancing devices and diabetes administration software. The business accounted for EUR 909 million in sales in 2014, with Contour™ being the principal product portfolio. The Contour™ portfolio comprises Contour™ Next, Contour™ Plus, Contour™ and Contour™ TS and is designed to meet the needs of all patients regardless of type of diabetes, stage of disease, or testing frequency. Other products comprise Breeze™2, Brio™, Entrust™, Elite™ and Microlet™ lancing devices.
KKR & Co. L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, administration buyouts, credit special situations, growth equity, mature, mezzanine, distressed, and middle market investments.
At the end of Friday’s trade, Humana Inc (NYSE:HUM)‘s shares dipped -0.04% to $202.22.
As part of its mission to assist close the gap between people and care, Humana Inc. (HUM) declared an innovative partnership with the American Diabetes Association (Association) to develop a consumer-centric diabetes curriculum and delivery model with the aim of assisting slow the progression of diabetes through engaging educational information based on the organization’s standards of medical care.
Type 2 diabetes can be effectively managed with appropriate education and self-administration behaviors. However, research shows that almost two-thirds of adults with type 2 diabetes do not receive any diabetes education1. Lack of standardization in diabetes education also often creates conflicting information for those who have the disease.
The new delivery model co-developed between Humana and ADA will be a first-of-its-kind offering content that is evidence-based, culturally relevant, engaging and accessible in multi-channel formats. Each year the Association publishes its Standards of Medical Care which provide clinicians with the evidence and established targets to attain the aims of diabetes care.
Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.
Nucor Corporation (NYSE:NUE), ended its Friday’s trading session with -1.25% loss, and closed at $47.50.
Nucor Corporation (NUE) declared the regular quarterly cash dividend of $0.3725 per share on Nucor’s common stock. This cash dividend is payable on August 11, 2015 to stockholders of record on June 30, 2015, and is Nucor’s 169th successive quarterly cash dividend.
Nucor and associates are manufacturers of steel products, with operating facilities primarily in the U.S. and Canada. Products produced comprise: carbon and alloy steel — in bars, beams, sheet and plate; steel piling; steel joists and joist girders; steel deck; fabricated concrete reinforcing steel; cold finished steel; steel fasteners; metal building systems; steel grating and expanded metal; and wire and wire mesh. Nucor, through The David J. Joseph Company, also brokers ferrous and nonferrous metals, pig iron and HBI/DRI; supplies ferro-alloys; and processes ferrous and nonferrous scrap. Nucor is North America’s largest recycler.
Nucor Corporation manufactures and sells steel and steel products in the United States and internationally. It operates through three segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment produces and distributes hot-rolled, cold-rolled, and galvanized sheet steel products; plate steel products; structural steel products comprising wide-flange beams, beam blanks, H-pilings, and sheet pilings; and bar steel products, such as blooms, billets, concrete reinforcing bars, merchant bars, and special bar quality products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
